← Leaderboards
Nadya Tarasova
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Generations”
- Richard A Gibbs · Baylor College Of Medicine$539,942,150
- David Heimbrook · Leidos Biomedical Research, Inc.$461,253,475
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Dennis R. Burton · Scripps Research Institute$280,469,869
- Eric S Lander · Whitehead Institute For Biomedical Res$262,517,055
Research focus
GenerationsMolecular ConformationStructureCellsPeptidesPermeabilityMouse ModelSignal TransductionInhibitor/AntagonistTumorAlpha HelixPharmaceutical PreparationsProteinsHigh Throughput ScreeningProstatic NeoplasmsMammary NeoplasmsSmall MoleculeLeadLigandsScreening ProcedureMembraneReceptorVirusProtein Protein Interaction
Grant awards (35)
Inhibitors of protein-protein interactions$669,111
ZIA · FY2025 · CA · contact PI
Large Databases of Small Molecules - Drug Development Tool and Public Resource$446,074
ZIC · FY2025 · CA · contact PI
Inhibitors of protein-protein interactions$1,060,173
ZIA · FY2024 · CA · contact PI
Development of COVID-19 cell entry inhibitors$32,788
ZIA · FY2024 · CA · contact PI
Inhibitors of protein-protein interactions$763,200
ZIA · FY2023 · CA · contact PI
Development of COVID-19 cell entry inhibitors$40,169
ZIA · FY2023 · CA · contact PI
Inhibitors of protein-protein interactions$696,075
ZIA · FY2022 · CA · contact PI
Self-assembling protoviral nanoparticles$37,830
ZIA · FY2022 · CA · contact PI
Development of COVID-19 cell entry inhibitors$22,698
ZIA · FY2022 · CA · contact PI
Inhibitors of protein-protein interactions$493,663
ZIA · FY2021 · CA · contact PI
Development of COVID-19 cell entry inhibitors$61,708
ZIA · FY2021 · CA · contact PI
Self-assembling protoviral nanoparticles$61,708
ZIA · FY2021 · CA · contact PI
Inhibitors of protein-protein interactions$379,465
ZIA · FY2020 · CA · contact PI
Development of COVID-19 cell entry inhibitors$303,572
ZIA · FY2020 · CA · contact PI
Self-assembling protoviral nanoparticles$75,893
ZIA · FY2020 · CA · contact PI
Inhibitors of protein-protein interactions$591,475
ZIA · FY2019 · CA · contact PI
Self-assembling protoviral nanoparticles$253,490
ZIA · FY2019 · CA · contact PI
Inhibitors of protein-protein interactions$531,607
ZIA · FY2018 · CA · contact PI
Self-assembling protoviral nanoparticles$227,831
ZIA · FY2018 · CA · contact PI
Self-assembling protoviral nanoparticles$369,655
ZIA · FY2017 · CA · contact PI
Inhibitors of protein-protein interactions$369,655
ZIA · FY2017 · CA · contact PI
Self-assembling protoviral nanoparticles$380,215
ZIA · FY2016 · CA · contact PI
Inhibitors of protein-protein interactions$380,215
ZIA · FY2016 · CA · contact PI
Inhibitors of protein-protein interactions$381,512
ZIA · FY2015 · CA · contact PI
Self-assembling protoviral nanoparticles$381,512
ZIA · FY2015 · CA · contact PI
Self-assembling protoviral nanoparticles$352,293
ZIA · FY2014 · CA · contact PI
Inhibitors of protein-protein interactions$352,293
ZIA · FY2014 · CA · contact PI
Self-assembling protoviral nanoparticles$247,356
ZIA · FY2013 · CA · contact PI
Inhibitors of protein-protein interactions$247,356
ZIA · FY2013 · CA · contact PI
Self-assembling protoviral nanoparticles$169,868
ZIA · FY2012 · CA · contact PI
Inhibitors of protein-protein interactions$169,868
ZIA · FY2012 · CA · contact PI
Self-assembling protoviral nanoparticles$30,667
ZIA · FY2011 · CA · contact PI
Inhibitors of protein-protein interactions$30,667
ZIA · FY2011 · CA · contact PI
Self-assembling protoviral nanoparticles$154,301
ZIA · FY2010 · CA · contact PI
Inhibitors of protein-protein interactions$154,301
ZIA · FY2010 · CA · contact PI